| Circulation
| [0003]
|
| Expert Rev Neurother.
| [0006]
|
| J Cereb Blood Flow Metab.
| [0011]
|
| Behav Brain Res.
| [0011]
|
| Stroke
| [0011]
|
| Neuropharmacology
| [0011]
|
| Cell Death Differ.
| [0012]
|
| Int J Mol Med.
| [0012]
|
| Stroke
| [0017]
|
| European Journal of Pharmacology
| [0017]
|
| Pharmaceutical Salts
| [0043]
[0057]
|
| No To Shinkei
| [0147]
|
| Ann Neurol
| [0148]
|
| Brain Res
| [0160]
|
| J. Neurosci
| [0161]
|
| J. Clin. Pharmacol.
| [0180]
|
| Spinal Cord
| [0180]
|
| Administration and Scoring Manual published by the National Multiple Sclerosis Society
| [0275]
|
| Age and Ageing.
| [0276]
[0277]
|
| Am J Occup Ther.
| [0277]
|
| Arch Phys Med Rehabil.
| [0279]
[0280]
[0282]
|
| Scand J Rehabil Med.
| [0283]
|
| Arch Phys Med Rehabil.
| [0286]
|
| Acute stroke management and prevention of recurrences. In Evidence-Based Neurology
| [0331]
|
| US cost burden of ischemic stroke: A systematic review
| [0331]
|
| Heart Disease and Stroke Statistics-2008 Update
| [0331]
|
| Heart Disease and Stroke Statistics 2009 Update: A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
| [0331]
|
| Disability status at one month is a reliable proxy for final ischemic stroke outcome
| [0331]
|
| Quality of Life among Stroke survivors evaluated 1 year after Stroke
| [0331]
|
| Understanding motor impairment in the paretic lower limb after Stroke: A review of the literature
| [0331]
|
| Neuroplasticity in the context of motor rehabilitation after stroke
| [0331]
|
| Exercise-mediated locomotor recovery and lower-limb neuroplasticity after stroke
| [0331]
|
| Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10171 in acute stroke treatment
| [0331]
|
| Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Sroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in research Interdisciplinary Working Groups
| [0331]
|
| Imaging Evaluation of Acute Ischemic Stroke
| [0331]
|
| Lifetime cost of stroke in the United States
| [0331]
|
| Dose comparison trial of sustained-release fampridine in multiple sclerosis
| [0331]
|
| Sustained-release oral fampridine in multiple sclerosis: a randomized, double-blind, controlled trial
| [0331]
|
| A Phase 2 trial of extended release oral dalfmapridine in multiple sclerosis
| [0331]
|
| Ischaemic stroke in adults and epilepsy
| [0331]
|
| Prevalence and predictors of early seizure and status epilepticus after first stroke
| [0331]
|
| A practical review and approach to poststroke seizures
| [0331]
|
| Seizures after stroke: A prospective multicenter study
| [0331]
|
| Incidence of seizures in the acute phase of stroke: A population-based study
| [0331]
|
| Predictors of acute post-stroke seizures
| [0331]
|
| Potassium channel blockers attenuate hypoxia and ischemia-induced neuronal death in vitro and in vivo
| [0331]
|
| Potassium channel blocker TEA prevents CA1 hippocampal injury following transient forebrain ischemia in adult rats
| [0331]
|
| Slowly inactivating potassium conductance (ID): A potential target for stroke therapy
| [0331]
|
| The Multiple Sclerosis Functional Composite Administration and Scoring Manual
| [0331]
|
| Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants
| [0331]
|
| Adult norms for the Box and Block Test of manual dexterity
| [0331]
|
| Grip and pinch strength; normative data for adults
| [0331]
|
| The post-stroke hemiplegic patient: a method for evaluation of physical performance
| [0331]
|
| Code of Federal Regulations, Title 21 Food and Drugs. In: Selected Regulations and Guidance for Drug Studies. Philadelphia, PA: Clinical Research Resources
| [0331]
|
| World Medical Association. Declaration of Helsinski
| [0331]
|
| Inter-and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity
| [0331]
|
| Heart disease and stroke statistics--2012 update: a report from the American Heart Association
| [0363]
|
| The alterations of oligodendrocyte, myelin in corpus callosum, and cognitive dysfunction following chronic cerebral ischemia in rats
| [0363]
|
| Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases
| [0363]
|
| Is white matter involved in patients entered into typical trials of neuroprotection
| [0363]
|
| Structural integrity of corticospinal motor fibers predicts motor impairment in chronic stroke
| [0363]
|
| Cerebral white matter hyperintensities predict functional stroke outcome
| [0363]
|
| Cerebral white matter is highly vulnerable to ischemia
| [0363]
|
| The axon: structure, function, and pathophysiology
| [0363]
|
| Ion channels and neuronal dysfunction in multiple sclerosis
| [0363]
|
| Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels
| [0363]
|
| Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord
| [0363]
|
| 4-Aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerve
| [0363]
|
| Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres
| [0363]
|
| The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres
| [0363]
|
| Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord
| [0363]
|
| Effects of 4-aminopyridine on stretched mammalian spinal cord: the role of potassium channels in axonal conduction
| [0363]
|
| Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury
| [0363]
|
| The use of 4-aminopyridine (fampridine) in demyelinating disorders
| [0363]
|
| Phase 2 trial of sustained-release fampridine in chronic spinal cord injury
| [0363]
|
| Dose comparison trial of sustained-release fampridine in multiple sclerosis
| [0363]
|
| A phase 3 trial of extended release oral dalfampridine in multiple sclerosis
| [0363]
|
| Dalfampridine (Ampyra) for multiple sclerosis
| [0363]
|
| Guide to the care and use of laboratory animals
| [0363]
|
| Focal cerebral infarction in the rat: I. Operative technique and physiological monitorings for chronic model
| [0363]
|
| Neocortical localization of tactile/proprioceptive limb placing reactions in the rat
| [0363]
|
| vated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism
| [0363]
|
| Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery
| [0363]
|
| Oligodendrocytes and ischemic brain injury
| [0363]
|
| Selective glial vulnerability following transient global ischemia in rat brain
| [0363]
|
| Demyelination in spinal cord injury and multiple sclerosis: what can we do to enhance functional recovery
| [0363]
|
| Enhancement of action potential conduction following demyelination: experimental approaches to restoration of function in multiple sclerosis and spinal cord injury
| [0363]
|
| Neuropathology of human spinal cord injury sustained in sports-related activities
| [0363]
|
| A review of the neuropathology of human spinal cord injury with emphasis on special features
| [0363]
|
| opyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit
| [0363]
|
| The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial
| [0363]
|
| Dalfampridine in multiple sclerosis
| [0363]
|
| Pharmacokinetics of an immediate-release oral formulation of Fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injury
| [0363]
|
| Intravenous infusion of 4-AP in chronic spinal cord injured subjects
| [0363]
|
| Motor cortex bilateral motor representation depends on subcortical and interhemispheric interactions
| [0363]
|
| A functional MRI study of subjects recovered from hemiparetic stroke
| [0363]
|
| Functional magnetic resonance imaging of reorganization in rat brain after stroke
| [0363]
|